Sort
23,748 grants matching “melanoma”
Melanocortin-1 Receptor Targeted Ultrasmall Silica nanoparticles for Alpha- and
$322,300Thomas P Quinn · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
Molecular pathogenesis of UVB-induced skin cancer
$322,294David Rinsey Bickers · Columbia University Health Sciences · R01 · FY2006 · CA
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC
$322,278James P Allison · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA
Store-operated calcium entry in tumor invasion and metastasis
$322,248Shengyu Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2017 · CA
BIGDATA: Collaborative Research: F: Big Data, It's Not So Big: Exploiting Low-Dimensional Geometry for Learning and Inference
$322,242Shayn Mukherjee · Duke University · · FY2015 · CSE
EFFECT OF GM-CSF AND VACCINE SITE NUMBER ON IMMUNIZATION WITH MELANOMA PEPTIDES
$322,205University Of Virginia Charlottesville · M01 · FY2005 · RR
Enhancing the vaccinal effect of antitumor antibodies
$322,040Angela M Christiano · Columbia University Health Sciences · R01 · FY2014 · CA
Tumor antigen-specific T-cells and hepatocellular carcinoma
$322,040David E Kaplan · University Of Pennsylvania · R01 · FY2014 · CA
Combined CD40 activation and CTLA4 blockade in melanoma
$322,040Robert H Vonderheide · University Of Pennsylvania · R01 · FY2014 · CA
Improving decision-making for older adults with melanoma
$322,000Jay Soong-Jin Lee · Duke University · R03 · FY2024 · AG
Regulation of heterotrimeric G proteins by non-receptor activators
$321,966Gregory Gordon Tall · University Of Rochester · R01 · FY2014 · GM
The Chernobyl Tissue Bank - Coordinating Center
$321,960Geraldine Anne Thomas · Imperial College Of Science, Technology And Medicine · U24 · FY2021 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$321,938Anna E Vilgelm · Ohio State University · R37 · FY2024 · CA
Protease Activated Receptors in Cancer Invasion
$321,925Tufts Medical Center · R01 · FY2005 · CA
GENETIC MODIFICATION OF HUMAN DENDRITIC CELLS FOR CANCER IMMUNITY
$321,909James W. Young · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Anti-Cancer Activities of PTPase Inhibitors
$321,891Taolin Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients
$321,889Eva Hernando · University Of New Mexico Health Scis Ctr · P01 · FY2019 · CA
Regulation of Chemokine Mediated Leukocyte Functions
$321,870Micheler Ricardo Richardson · North Carolina Central University · R01 · FY2008 · AI
Generation of Anti-Melanoma T Cells Derived from Human Embryonic Stem Cells
$321,862Jerome A. Zack · California Institute Of Technology · P01 · FY2014 · CA
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
$321,841Duane A. Mitchell · Duke University · R01 · FY2010 · CA
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
$321,841Duane A. Mitchell · Duke University · R01 · FY2009 · CA
Synergistically Acting Targeted Therapeutics for Melanoma
$321,833Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · CA
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
$321,825Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2024 · CA
Delivery of cytokines for cancer immunotherapy using nanolayer-controlled trafficking of liposomal nanoparticles
$321,799Paula T Hammond · Massachusetts Institute Of Technology · R01 · FY2021 · CA
Delivery of cytokines for cancer immunotherapy using nanolayer-controlled trafficking of liposomal nanoparticles
$321,799Paula T Hammond · Massachusetts Institute Of Technology · R01 · FY2019 · CA